PHARMACEUTICAL COMPOSITION I CONTEND EXTRACTED [EUPOMATENOIDE]-5 DE [PIPER] REGNELLI AND ITS USE IN DESTIN

NOVELTY – Pharmaceutical composition comprises eupomatenoid-5 and pharmaceutically acceptable excipients. USE – Pharmaceutical composition used as drug composition for treatment of cancer (all claimed). ADVANTAGE – The pharmaceutical composition shows anticancer activity low cytotoxicity.

Main Application Field

B04 (Natural products and polymers. Including testing of body fluids (other than blood typing or cell counting), pharmaceuticals or veterinary compounds of unknown structure, testing of microorganisms for pathogenicity, testing of chemicals for mutagenicity or human toxicity and fermentative production of DNA or RNA. General compositions.)

INVENTORS:

DE CARVALHO JOCO ERNESTO
LONGATO GIOVANNA BARBARINI
RUIZ ANA LECIA TASCA GOES
FOGLIO MARY ANN
FIGUEIRA GLYN MARA

412_ATIVIDADE ANTI

Patent number: BR201003682-A2

PATENT STATUS:

For information contact Inova Unicamp

FOR ADDITIONAL INFORMATION:

parcerias@inova.unicamp.br

+55 (19) 3521-5207 / 2607

This technology profile has been automatically generated.